Minister of Health Ab Klink (CDA) have been awarded the tender decision about the vaccine against cervical cancer not reviewed. The court in The Hague Monday has a debt of the company Sanofi Pasteur MSD end, rejected.
Klink wants all girls of 12 years and older from September next year be vaccinated against cervical cancer. To determine which manufacturer the vaccine may provide organized the Netherlands Vaccine Institute (NVI) Klink in command of an international tender. That yielded offers of the British company Glaxo Smith Kline (GSK) with an office in Warri and the French Sanofi-American in Hoofddorp.
The NSA wants the production of the vaccine directly to GSK, which means Cevarix on the market. Sanofi, producer of medium Gardasil, signed them objected to the court. The company claimed, inter alia, the quality differences between the vaccines are insufficient placed next to each other.
Provisioning court verdict Monday in the late mention that Sanofi has signaled its objections. For the registration date, the alleged imperfections in the tendering process must be seized. The right to complain, the company has thus wasted, the court held, which would be the main defense of the state honoreerde.
Sanofi also questioned the independence of the Health in doubt. The decision to the large-scale vaccination from September next year followed an opinion of that council. The court also pointed out that claim, because the political decisions of Klink and the opinion beyond the scope of the tender traps. Therefore stood in the interim order, according to the court not in question.
Research Zembla suggested recently that the advisory board of the Health several scientists who maintain ties with the two manufacturers of a vaccine. Researchers and doctors warned late August in the English journal of Medicine for a hasty introduction of the nationwide vaccination. Klink said last month that it will not be postponed.
Klink wants all girls of 12 years and older from September next year be vaccinated against cervical cancer. To determine which manufacturer the vaccine may provide organized the Netherlands Vaccine Institute (NVI) Klink in command of an international tender. That yielded offers of the British company Glaxo Smith Kline (GSK) with an office in Warri and the French Sanofi-American in Hoofddorp.
The NSA wants the production of the vaccine directly to GSK, which means Cevarix on the market. Sanofi, producer of medium Gardasil, signed them objected to the court. The company claimed, inter alia, the quality differences between the vaccines are insufficient placed next to each other.
Provisioning court verdict Monday in the late mention that Sanofi has signaled its objections. For the registration date, the alleged imperfections in the tendering process must be seized. The right to complain, the company has thus wasted, the court held, which would be the main defense of the state honoreerde.
Sanofi also questioned the independence of the Health in doubt. The decision to the large-scale vaccination from September next year followed an opinion of that council. The court also pointed out that claim, because the political decisions of Klink and the opinion beyond the scope of the tender traps. Therefore stood in the interim order, according to the court not in question.
Research Zembla suggested recently that the advisory board of the Health several scientists who maintain ties with the two manufacturers of a vaccine. Researchers and doctors warned late August in the English journal of Medicine for a hasty introduction of the nationwide vaccination. Klink said last month that it will not be postponed.
No comments:
Post a Comment